NORTHEAST PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.58 CNY | -4.98% |
|
-1.29% | -14.39% |
| Sales 2022 | 8.81B 1.22B 101B | Sales 2023 | 8.24B 1.14B 94.85B | Capitalization | 7.65B 1.06B 87.98B |
|---|---|---|---|---|---|
| Net income 2022 | 350M 48.3M 4.03B | Net income 2023 | 358M 49.41M 4.12B | EV / Sales 2022 | 0.84 x |
| Net cash position 2022 | 1.65B 227M 18.96B | Net cash position 2023 | 3.47B 479M 39.91B | EV / Sales 2023 | 0.51 x |
| P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
21.4
x | Employees | 6,214 |
| Yield 2022 |
1.58% | Yield 2023 |
1.87% | Free-Float | 41.71% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.98% | ||
| 1 week | -1.29% | ||
| Current month | -3.98% | ||
| 1 month | -3.78% | ||
| 3 months | -5.37% | ||
| 6 months | -8.58% | ||
| Current year | -14.39% |
1 week
4.54
4.83
1 month
4.415.04
Current year
3.775.48
1 year
3.776.00
3 years
3.779.30
5 years
3.779.30
10 years
2.889.30
| Managers | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CEO | Chief Executive Officer | 60 | 01/05/01 |
Yang Cai
SEC | Corporate Secretary | 39 | 08/19/08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CEO | Chief Executive Officer | 60 | 01/05/01 |
Guo Dong Wang
BRD | Director/Board Member | 82 | 18/18/18 |
Zhao Chun Tan
BRD | Director/Board Member | 59 | 17/21/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 4.58 | -4.98% | 33,919,550 |
| 25/24/25 | 4.82 | +1.90% | 11,983,540 |
| 24/24/24 | 4.73 | +0.42% | 7,584,470 |
| 23/24/23 | 4.71 | +0.64% | 8,210,008 |
| 22/24/22 | 4.68 | +0.86% | 9,271,217 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Northeast Pharmaceutical Group Co., Ltd. specializes in the production and marketing of pharmaceutical ingredients and preparations. The group's products include antibiotics, vitamins, cardiovascular treatments, anesthetics, medical plants, etc.
China accounts for 86.3% of net sales.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.39% | 903M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 000597 Stock
